The greater frequency of CD4+ CD28− in subjects with ischemic stroke compared to controls and the significant association with the degree and type of neurological deficit and with the cardioembolic subtype offers the possibility to analyze a possible application of the peripheral levels of the T-cell subset for differentiate stroke and its diagnostic subtype. This evidence concerns the gene CD4 and stroke disorder.